basics

The Endocannabinoid System, Explained

Your body has a built-in system designed to interact with cannabis compounds. Understanding the ECS explains why cannabis works.

By DCWeedHub Editorial · Published · Updated

The Endocannabinoid System, Explained

Short answer: The endocannabinoid system (ECS) is a signaling system found throughout the body. Peer-reviewed reviews describe it as having three parts: cannabinoid receptors (mainly CB1 and CB2), endocannabinoids the body makes itself (mainly anandamide and 2-AG), and the enzymes that make and break them down (Lu & Mackie 2016). THC produces its effects mainly by acting on these cannabinoid receptors (Lu & Mackie 2016). Here's how it was discovered, what we know, and what we don't.

Planning to buy from a licensed DC store? Register first: start your ABCA registration.

How the ECS was discovered

Researchers found the system by working backward from the plant:

  • 1990: Scientists cloned a cannabinoid receptor from rat brain tissue, the receptor now called CB1 (Matsuda et al., Nature 1990).
  • 1992: They identified the first endocannabinoid, a brain compound that binds the cannabinoid receptor, and named it anandamide (Devane et al., Science 1992).
  • 1993: They identified a second receptor, now called CB2, found outside the brain (Munro et al., Nature 1993).

So the system is named after the plant that led researchers to it, not the other way around.

The three parts

1. Receptors. Lu and Mackie call CB1 the most abundant cannabinoid receptor. CB2 is the second. They note that some cannabinoids also act on other targets, including TRP channels and PPARs (Lu & Mackie 2016).

2. Endocannabinoids. The two best-studied are 2-arachidonoyl glycerol (2-AG) and anandamide. They're made and broken down by different enzyme pathways, which gives them "fundamentally different" roles (Lu & Mackie 2016).

3. Enzymes. These make endocannabinoids when they're needed and break them down afterward (Lu & Mackie 2016).

What the ECS does

Lu and Mackie describe the ECS as a widespread neuromodulatory system with important roles in central nervous system development, synaptic plasticity (how connections between nerve cells strengthen or weaken), and the body's response to internal and environmental insults (Lu & Mackie 2016).

Popular articles often say the ECS "regulates" a long list of functions, such as mood, sleep, appetite and pain, and present that as proof cannabis treats those things. That's a leap. A system being involved in a process doesn't mean a cannabis product will improve it. For what the clinical evidence actually shows, see cannabis and sleep and cannabis and anxiety.

How THC and CBD interact with it

  • THC is a partial agonist at both CB1 and CB2. Russo's review says this receptor activity underlies many of THC's effects, including its psychoactive effects (Russo 2011).
  • CBD isn't intoxicating (NIDA). It acts differently from THC. Russo's review describes it as having little binding affinity for CB1. In the presence of THC, though, it can still act as a CB1 antagonist, and the review lists several other proposed actions (Russo 2011). How much each of those matters in people is still being studied.
  • Beta-caryophyllene, a terpene found in cannabis and black pepper, binds CB2 in lab studies (Gertsch et al. 2008). Lab binding doesn't show an effect in people. See terpenes explained.

Why people respond differently

Why do two people respond so differently to the same product? The full answer is UNKNOWN. Known factors include how a product is taken, since inhaled and oral THC are absorbed and processed differently (Grotenhermen 2003; Huestis 2007), and the product's THC content (NIDA). See consumption methods and the start-low dosing guide.

What this page doesn't claim

We don't claim the ECS explains why cannabis "works" for any condition. The FDA hasn't approved the cannabis plant for any medical use (NCCIH).

Frequently asked questions

What is the endocannabinoid system?

It's a signaling system made up of cannabinoid receptors, endocannabinoids the body makes, and the enzymes that make and break them down (Lu & Mackie 2016).

When was the endocannabinoid system discovered?

The key findings came in the early 1990s: the CB1 receptor was cloned in 1990, anandamide was identified in 1992, and CB2 in 1993 (Matsuda 1990; Devane 1992; Munro 1993).

Does THC bind to CB1 receptors?

Yes. THC is a partial agonist at the CB1 and CB2 cannabinoid receptors (Russo 2011).

Does CBD bind to the same receptors as THC?

Not in the same way. Russo's review describes CBD as having little binding affinity for CB1, with other proposed mechanisms (Russo 2011).

Keep reading

Sources

Last updated: October 26, 2026. Educational information only, not medical advice. 21+.